N,1-dimethyl-1H-imidazol-2-amine hydrochloride, 95.0%, 500mg

N'-(4-chloro-1,3-benzothiazol-2-yl)-N,N-dimethylethane-1,2-diamine, 95.0%, 500mg

5-Bromo-6-hydroxypicolinic acid, 95.0%, 250mg

3,6-Dibromopicolinaldehyde, 98%, 1g

2-(4-Methanesulfonylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

Methyl 2-Bromo-5-fluorobenzoate>98.0%(GC)5g

1,4-Diacetoxybutane>98.0%(GC)500g

3-Benzyl-2-bromo-9-methyl-4H,6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,4]oxazepine, 98%, 100mg

(R)-2-amino-4,4,4-trifluoro-butyric acid hydrochloride, 1g

GC capillary column ROTI®Cap-5 MS Ultra, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

4-Amino-2-ethylaminopyridine, 95.0%, 250mg

(2E)-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

(3-Methyl-4-nitrophenyl)methanol, 95.0%, 5g